Prothena Corporation plc
Prothena to Present at the Oppenheimer 25th Annual Healthcare Conference in New York
DGAP-News: Prothena Corporation 08.12.2014 / 22:05 --------------------------------------------------------------------- DUBLIN, 2014-12-08 22:05 CET (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve amyloid or cell adhesion, announced that Tran Nguyen, the Company's Chief Financial Officer, will be presenting at the Oppenheimer 25th Annual Healthcare Conference on Thursday, December 11, 2014, at 10:55 AM EST. The conference will be held at the Crowne Plaza Hotel in New York. A live webcast of the presentation can be accessed through the investor relations section of the Company's website at www.prothena.com. Following the live presentation, a reply of the webcast will be available on the Company's website for 90 days. About Prothena Prothena Corporation plc is a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve amyloid or cell adhesion. The Company focuses on therapeutic monoclonal antibodies directed specifically to disease-causing proteins and its antibody-based product candidates target a number of potential indications including AL and AA forms of amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002) and novel cell adhesion targets involved in psoriasis and other inflammatory diseases (PRX003). For more information, please visit the Company's web site at www.prothena.com. CONTACT: Investors: Tran Nguyen, CFO 650-837-8535, IR@prothena.com Media: Angela Bitting 925-202-6211, angela.bitting@prothena.com News Source: NASDAQ OMX --------------------------------------------------------------------- 08.12.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Prothena Corporation Ireland ISIN: IE00B91XRN20 End of News DGAP News-Service --------------------------------------------------------------------- 303601 08.12.2014
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden